- Home
- ATEX vs HQL Comparison
ATEX vs HQL Comparison
Compare ATEX & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATEX | HQL |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Investment Managers |
| Sector | Telecommunications | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.4M | 490.5M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATEX | HQL |
|---|---|---|
| Price | $38.79 | $16.26 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | ★ 287.9K | 105.3K |
| Earning Date | 02-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.85 | 0.79 |
| Revenue | ★ $6,031,000.00 | N/A |
| Revenue This Year | $2.70 | N/A |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | ★ $10.18 | $20.54 |
| Revenue Growth | ★ 43.90 | N/A |
| 52 Week Low | $17.58 | $10.55 |
| 52 Week High | $40.86 | $17.80 |
Technical Indicators
Market Signals| Indicator | ATEX | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 61.18 | 42.05 |
| Support Level | $20.12 | $15.66 |
| Resistance Level | $40.34 | $17.51 |
| Average True Range (ATR) | 2.07 | 0.31 |
| MACD | -0.34 | -0.01 |
| Stochastic Oscillator | 53.23 | 41.27 |
Price Performance
Historical ComparisonAbout ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.